The RNA Liquid biopsy company

Platform

End-to-end tech stack for cfRNA

Publications

Urine Cell-Free RNA vs Plasma Cell-Free RNA for Monitoring of Kidney Injury and Immune Complications
Circulating cell-free RNA in blood as a host response biomarker for detection of tuberculosis
Plasma Cell-Free RNA Captures Immune Dynamics and Predicts GVHD after Hematopoietic Stem Cell Transplantation
Plasma cell-free RNA signatures of inflammatory syndromes in children
Molecular characterization of Kawasaki disease subgroups using cell-free RNA profiling
Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C
Minimal Correlation but Complementary Diagnostic Utility for Plasma Cell-free RNA and Proteins
Circulating cell-free RNA signatures for the characterization and diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome
Genome and clonal hematopoiesis stability contrasts with immune, cfDNA, mitochondrial, and telomere length changes during short duration spaceflight
Spatiotemporal expression and control of haemoglobin in space
Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight
The Space Omics and Medical Atlas (SOMA) and international astronaut biobank
Liquid Biquid Biopsy Based on Cell-Free DNA and RNA

Founding Team

Conor Loy, PhD

CEO
David McKellar, PhD

CTO
Iwijn De Vlaminck, PhD

Advisor